
27/03/26
Demineralized Bone Matrix: The biological advancement that can redefine bone regeneration in implantology Baumer
Demineralized Bone Matrix: The biological advancement that can redefine bone regeneration in implantology.
In recent years, implantology has incorporated increasingly sophisticated biomaterials to optimize bone regeneration and make clinical protocols more predictable. Among these innovations is DBM (Demineralized Bone Matrix), a biomaterial capable of acting as a three-dimensional biological scaffold, favoring cellular migration, vascularization, and the formation of new bone tissue. Baumer introduces this technology to the national market with two demineralized bone matrix solutions: Orthosoft and GenMatrix, expanding access for Brazilian implantologists to a biomaterial that can contribute to more efficient bone regeneration and a potential reduction in clinical treatment time. In this article, we will explore Orthosoft in detail, its biological characteristics, and its applications in implantology practice.
The demineralized bone matrix used in Orthosoft is obtained from the cancellous portion of bovine bone tissue, subjected to a physicochemical process that removes mineral components while preserving the organic fraction and the tissue's three-dimensional architecture. This processing maintains the material's porous structure, allowing it to act as an osteoconductive scaffold, favoring the migration of osteoprogenitor cells and the formation of new blood vessels from the recipient bed. Through this biological interaction, the matrix begins to function as a support for cell adhesion and proliferation, being gradually resorbed and replaced by functional new bone during the bone regeneration process.
Would you like to learn in detail about the technology behind Orthosoft and how it can be applied to your clinical practice? Contact the Baumer sales team and learn more about this innovation in bone regeneration.
[Click here to join the Baumer mailing list] For more information about products or to speak with our sales team:
📧 Email: odonto@baumer.com.br
📱 WhatsApp: +55 (11) 97399-5605 — or [Click here to contact us] 📞 Phone: +55 (11) 3670-0022
Clinical Indications for Demineralized Bone Matrix — Orthosoft
In implantology, the use of demineralized bone matrices expands the possibilities for reconstructing bone defects in various clinical scenarios. Orthosoft is indicated as a graft material for filling bone defects in the maxillofacial region, especially in situations where there is a loss of bone volume due to trauma, surgical procedures, or associated pathologies. Its main clinical applications include:
Post-extraction Alveolar Preservation: After tooth extraction, filling the socket with demineralized bone matrix contributes to maintaining bone volume, reducing physiological resorption and favoring the preservation of alveolar architecture for future implant placement.
Guided Bone Regeneration (GBR): In bone defects associated with implant placement, Orthosoft can be used in conjunction with barrier membranes, assisting in bone tissue regeneration and the reconstruction of the volume necessary for implant stability and osseointegration.
Reconstruction of Peri-implant Defects: In cases of bone loss around implants, the matrix acts as a support for bone tissue regeneration, favoring the filling of the defect and the recovery of the bone structure around the implant.
Bone Volume Augmentation in Atrophic Areas: In regions with bone volume deficiency, the material can be used for partial reconstruction of the alveolar ridge, allowing for the creation of a more favorable environment for implant rehabilitation procedures.
The versatility of the material allows it to be used alone or in association with other biomaterials, depending on the surgical strategy adopted by the professional.
Clinical Advantages of Orthosoft in Bone Regeneration
Among the clinical differentiators of Orthosoft is the possibility of reducing or even eliminating the need for autogenous bone graft harvesting. In many bone regeneration procedures, the surgeon needs to remove bone from the patient themselves—usually from intraoral areas like the mandibular ramus or chin, or extraoral regions—to use as graft material. This process requires the creation of a second surgical site, increasing operative time, procedure complexity, and postoperative morbidity.
By using a demineralized bone matrix like Orthosoft, the professional has a biomaterial that acts as an osteoconductive scaffold, capable of promoting cellular migration and the formation of new bone tissue at the grafted site. In this way, it is possible to reduce the need to harvest the patient's own bone, making the procedure less invasive, more surgically efficient, and potentially more comfortable for the patient.
Furthermore, the preservation of the organic structure and the porous architecture of the material favors its rapid hydration and integration with the recipient bed, creating suitable conditions for vascularization and the initiation of the bone regeneration process.
Ease of Handling and Clinical Efficiency with Orthosoft
Another relevant aspect of Orthosoft in clinical practice is related to the ease of handling the biomaterial during the surgical procedure. The demineralized bone matrix features a porous structure that allows for rapid hydration with sterile saline solution or the patient's own blood, acquiring a more homogeneous consistency suitable for insertion into the bone defect.
In surgical practice, this characteristic translates into greater control of the material during handling and insertion into the bone bed, allowing the implantologist to fill the area with greater precision and adaptation to the defect. After hydration, the material exhibits greater cohesion between particles, facilitating its placement in the surgical site and contributing to graft stability during the procedure.
From an operative standpoint, this ease of handling can make the procedure smoother and more predictable for the surgeon, reducing the complexity of managing the biomaterial in the surgical field and favoring the adaptation of the graft to the morphology of the bone defect.
Additionally, by acting as a biological scaffold for cell migration and new bone formation, Orthosoft can contribute to more predictable and potentially faster regenerative protocols, which may result in a reduction in total treatment time for the patient and greater clinical efficiency for the professional.
Biological Predictability and Replacement by New Bone
In bone regeneration, the predictability of the biological process is a determining factor for the success of implant procedures. Biomaterials that offer a favorable environment for vascularization, cell adhesion, and bone remodeling contribute to more consistent and safe clinical results.
The demineralized bone matrix in Orthosoft acts as a porous three-dimensional structure that favors the entry of blood capillaries and the migration of osteoprogenitor cells from the recipient bed. This biological microenvironment allows the material to function as a support for cell deposition and the formation of new bone tissue, actively participating in the regenerative process.
Throughout the healing process, the biomaterial is gradually resorbed and replaced by functional new bone, allowing the treated area to regain its bone structure and provide suitable conditions for the placement and maintenance of dental implants.
This biological dynamic contributes to making regenerative procedures more predictable from a clinical perspective, reinforcing the role of demineralized bone matrix as a relevant alternative within the implantologist's therapeutic arsenal.
As implantology evolves, biomaterials capable of combining biology, predictability, and clinical efficiency become increasingly relevant in the implantologist's practice. Demineralized bone matrix represents precisely this advancement, offering a favorable environment for bone regeneration and expanding therapeutic possibilities in different clinical scenarios. With Orthosoft, Baumer brings a solution based on this technology to the Brazilian market, produced domestically and developed to support increasingly efficient regenerative protocols. For the professional looking to incorporate new approaches in bone regeneration, it may be time to take a closer look at this innovation—and talk to the Baumer team to understand how Orthosoft can be integrated into your clinical protocols.
Would you like to learn more about Orthosoft and understand how to incorporate this technology into your clinical protocols? Contact the Baumer sales team and discover how this innovation can become part of your implantology practice.